National Research Corporation (NRC)

In the past six months, NRC's stock price increased by 22.94% over the last month and 21.14% over the last six months as of early January 2026. On October 27, 2025, NRC Health announced its third-quarter 2025 results, reporting total revenue of $34.6 million and Adjusted EBITDA of $10.9 million. The company's Total Recurring Contract Value (TRCV) was $141.7 million. During the third quarter of 2025, NRC repurchased 618,264 shares at a weighted average price of $14.99 per share. On October 15, 2025, the Board of Directors declared a quarterly cash dividend of $0.16 per share. In November and December 2025, NRC Health announced several new partnerships to enhance patient experience. The stock reached a 52-week low of $9.76 on April 20, 2025, and a 52-week high of $19.86. As of January 9, 2026, the market capitalization was $446.81 million.

The provided information does not offer specific details regarding the demand seasonality for National Research Corp.'s products and services. The company's subscription-based Software-as-a-Service (SaaS) model suggests a recurring revenue stream, which might imply less pronounced seasonality compared to transactional businesses.

National Research Corporation, now known as NRC Health, was founded in 1981 and is based in Lincoln, Nebraska. It operates in the Health Information Services industry, providing subscription-based healthcare intelligence, analytics, and insights to healthcare organizations in the U.S. and Canada through its SaaS model. NRC Health offers patient experience solutions, employee experience solutions, reputation solutions, market experience solutions, consumer experience solutions, governance solutions, and Huey AI.

National Research Corporation primarily serves healthcare organizations across the United States and Canada. The company's headquarters are located in Lincoln, Nebraska, U.S.

NRC Health's brand reputation in the past year has been focused on its commitment to "Human Understanding®" in healthcare. In April 2025, NRC Health unveiled its 2025 Experience Perspective Report. The company has formed partnerships with various healthcare systems to advance patient experience. NRC Health aims to help its clients overcome the challenge of brand differentiation by providing market insights and tools to build brand presence and preference.

National Research Corporation's ownership includes institutional investors, company insiders, and retail/public investors. Institutional investors hold a substantial portion of the stock, ranging from approximately 34.79% to 56% of outstanding shares. Company insiders hold a considerable percentage, around 42.71% to 58.31% of the company. Retail/Public Investors hold a smaller portion, estimated between 2.04% and 14.09%.